Friday, November 20, 2009
Print Current Day:
|
|
SESSION 18 SCHEDULE | |
x | |
7:30 AM - 7:40 AM | Stent-Graft vs. Nitinol Stent For SFA Occlusive Disease: Results Of The VIBRANT Trial |
7:40 AM - 7:50 AM | Edge Stenosis After SFA Stents Or Stent-Grafts: Prevention And Management |
Presenters(s):Richard R. Saxon, MD | |
7:50 AM - 8:00 AM | Subintimal Angioplasty For SFA And Tibial Revascularization: Techniques For Improved Results |
8:00 AM - 8:20 AM | Panel Discussion |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Friday
SESSION 19:
AORTA
Moderators:TBD
|
|
x | |
8:20 AM - 8:30 AM | Endovascular Management Of Type B Dissections: What Works Best? |
8:30 AM - 8:40 AM | Aortic Arch Aneurysms Can Be Treated With Branched Endografts |
8:40 AM - 8:50 AM | Clinical Experience With A New Fenestrated Endograft For Pararenal AAA |
8:50 AM - 9:00 AM | Do Small AAAs Need To Be Treated: Results Of Randomized Trials |
9:00 AM - 9:10 AM | Aortic Coarctation Is Best Managed With Serial Dilatation Of An ICAST Covered Stent |
Presenters(s):Elchanan Bruckheimer, MBBS | |
9:10 AM - 9:20 AM | Are There Conditions That Predispose To Type II Endoleaks |
Presenters(s):Robert A. Lookstein, MD, FSIR, FAHA | |
9:20 AM - 9:30 AM | How And Why I Use Onxy To Treat Type II Endoleaks |
Presenters(s):Plinio Rossi, MD | |
9:30 AM - 9:40 AM | How And Why I Use Glue To Treat Type II Endoleaks |
Presenters(s):Robert J. Rosen, MD | |
9:40 AM - 10:00 AM | Panel Discussion |
10:10 AM - 10:30 AM | Break |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Friday
SESSION 20:
RENAL TUMORS
Moderators:TBD
|
|
x | |
10:30 AM - 10:40 AM | Preoperative Renal Embolization For Renal Cell Tumors |
Presenters(s):Curtis W. Bakal, MD, MPH | |
10:40 AM - 10:50 AM | Percutaneous Temporary Vessel Occlusion With A Reversible Thermoplastic Polymer For Bloodless Minimal Invasive Renal Surgery (LEGOO) |
Presenters(s):Sebastian Flacke, MD, PhD | |
10:50 AM - 11:00 AM | Management Of Renal Tumors – Transarterial And Percutaneous: The Whole Gamut |
11:00 AM - 11:10 AM | Debate: Percutaneous Cryotherapy Has An Important Role In The Management Of Renal Tumors |
Presenters(s):Timothy W.I. Clark, MD | |
11:10 AM - 11:20 AM | Debate: Percutaneous Cryotherapy Has A Minimal (If Any) Role In The Management Of Renal Tumors |
Presenters(s):Reza Ghavamian, MD | |
11:20 AM - 11:30 AM | Panel Discussion |
END OF SESSION 20 | |
SESSION 21 SCHEDULE | |
x | |
11:30 AM - 11:40 AM | Pathophysiology Of Portal Hypertension |
Presenters(s):John F. Reinus, MD | |
11:40 AM - 11:50 AM | Portal Vein And SVM Thrombosis: Should I Treat It, And If So, How? |
11:50 AM - 12:00 PM | Why And How To Narrow A TIPS |
Presenters(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
12:00 PM - 12:10 PM | (BRTO) Balloon-Occluded Retrograde Transvenous Obliteration For The Treatment Of Gastric And Esophageal Varices: Indications And Techniques |
12:10 PM - 12:20 PM | Panel Discussion |
12:20 PM - 1:00 PM | Lunch Break |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Friday
SESSION 22:
INTERVENTIONAL ONCOLOGY: LIVER AND CANCER METASTASES
xxxx
Moderators:Jean Francois H. Geschwind, MD
|
|
x | |
1:00 PM - 1:10 PM | Liver Transplant And The Interventional Radiologist |
Presenters(s):Paul J. Gaglio, MD | |
1:10 PM - 1:20 PM | UNOS Criteria For Liver Transplantation: How It Effects Choice Of Surgery vs. Local Regional Therapy |
Presenters(s):Milan Kinkhabwala, MD | |
1:20 PM - 1:30 PM | Percutaneous Management Of Post Liver Transplant Complications |
Presenters(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
1:30 PM - 1:40 PM | Volumetric Measurements And Portal Vein Embolization To Facilitate Partial Hepatectomy |
1:40 PM - 1:50 PM | CO2 DSA For Interventional Oncology |
Presenters(s):James Caridi, MD | |
1:50 PM - 2:00 PM | PRECISION V Study: Conventional TACE vs. DC Beads For Treatment Of HCC: A Randomized Trial |
2:00 PM - 2:10 PM | RFA For HCC |
2:10 PM - 2:20 PM | Cyberknife vs. Percutaneous Ablation Techniques: Results In Lung And Liver Tumors |
2:20 PM - 2:30 PM | Percutaneous Hepatic Artery Infusion Of Chemotherapy With Venous Filtration: The Delcath System |
2:30 PM - 2:40 PM | IRE: Is It The Holy Grail For The Treatment Of Pancreatic Cancer? |
2:40 PM - 2:50 PM | Fiducial Implantation For Sterotactic Radiotherapy: How I Do It |
2:50 PM - 3:00 PM | Drug Eluting Beads: The Italian Experience Using Combined Therapy |
Presenters(s):James Caridi, MD | |
3:00 PM - 3:10 PM | Bland Embolization And RFA At Same Session: Advantages And Disadvantages |
3:10 PM - 3:20 PM | Hepatic Arterial Management Of Metastatic Neuroendocrine Tumors |
Presenters(s):Karen T. Brown, MD | |
3:20 PM - 3:30 PM | Y90 Embolization For Hepatic Metastases |
3:30 PM - 3:40 PM | Tissue Characteristics After Ablation (RF, Cryo, MW, IRE) Of Liver Tumors: Is There Prognostic Value? |
Presenters(s):Constantinos T. Sofocleous, MD, PhD | |
3:40 PM - 3:50 PM | Interventional Oncology + Molecular Imaging = The Future Of Cancer Therapy |
3:50 PM - 4:00 PM | What, If Any Interventional Oncology Procedures Can Be Done In An Outpatient Setting? |
4:00 PM - 4:10 PM | The Future Of Interventional Oncology |
Presenters(s):Jean Francois H. Geschwind, MD | |
4:10 PM - 4:20 PM | Panel Discussion And Closing Remarks |
4:20 PM - 4:20 PM | Adjourn |
END OF SESSION 22 |